ZyVersa Therapeutics ZVSA
OTC ZVSA
$0.00 -0.05 (-100.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

ZyVersa Therapeutics, Inc. (ZVSA) Operating Income (2022 - 2026)

Updated

ZyVersa Therapeutics' Operating Income came in at -$1.3 million for Q1 2026, compared with -$2.14 million a year earlier.

Analysis

ZyVersa Therapeutics, Inc. (ZVSA) Operating Income (2022 - 2026) Analysis & Trends

Over the trailing twelve months to Mar 31, 2026, ZyVersa Therapeutics reported Operating Income of -$24.65 million; for FY2025, it came in at -$25.49 million.

  • Going back by year, Operating Income was -$9.14 million in FY2024, -$107.75 million in FY2023 and -$13.01 million in FY2022.
  • The five-year range for quarterly Operating Income is -$86.33 million (Q2 2023) to -$498,752 (Q2 2022).
  • Business Quant data shows ZVSA's Operating Income at -$551,858 (Q4 2025), -$20.75 million (Q3 2025) and -$2.04 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.30 Mn
Dec 31, 2025 -551,858.00
Sep 30, 2025 -20.75 Mn
Jun 30, 2025 -2.04 Mn
Mar 31, 2025 -2.14 Mn
Dec 31, 2024 -1.29 Mn
Sep 30, 2024 -2.27 Mn
Jun 30, 2024 -2.75 Mn
Mar 31, 2024 -2.83 Mn
Dec 31, 2023 -13.93 Mn
Sep 30, 2023 -2.90 Mn
Jun 30, 2023 -86.33 Mn
Mar 31, 2023 -4.59 Mn
Jun 30, 2022 -498,752.00
Mar 31, 2022 -801,048.00
API Access

ZyVersa Therapeutics, Inc. Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=ZVSA&period=max&api_key=YOUR_API_KEY